Bain Capital to buy Japanâs Mitsubishi Tanabe Pharma for $3.3 billion
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Indians are struggling to maintain a balance between digital workplace and life, with just three out of 100 individuals, according to a survey,.
Globus Medical, a US-based medical device company, will buy Nevro Corp. for $250 million in an all-cash deal.
United Therapeutics Corporation, a public benefit corporation, got approval from US regulators to start a clinical trial for organ transplantation from genetically modified.
HQ Team February 6, 2025: The U.S. Food and Drug Administration (FDA) issued a critical Class I recallâthe most severe categoryâfor Medtronicâs Becker.
Bharti Jayshankar February 5, 2025: Depression, a mental health condition affecting over 280 million people worldwide, is often accompanied by significant changes in.
Supernus Pharmaceuticals Incâs injection for treating people with advanced Parkinsonâs disease got a green light from the US regulator after two earlier rejections.
All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.
The worldâs first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the.
Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US governmentâs accusations against the global.